This review highlights that ectopic fat accumulation, rather than general subcutaneous adiposity, is a key driver of cardiometabolic risk and systemic metabolic alterations.
Answers are grounded in this paper and cite their sources.
No data extracted from source; leaves open ectopic fat's role in cardiometabolic risk.
Summary Obesity is a major risk factor for cardiovascular disease and its complications. However, not all fat depots share the same characteristics. Recent studies have found that ectopic rather than subcutaneous fat accumulation is associated with increased cardiometabolic risk. However, ectopic fat accumulation can be seen initially as a protective mechanism against lipotoxicity. Subsequently the adipose tissue becomes dysfunctional, thus inducing systemic metabolic alterations (through release of cytokines) or specific organ dysfunctions. The purpose of this review is to summarise the current available data on the impact of excess adiposity vs ectopic fat in the development of cardiometabolic diseases.
No takes yet. Share an insight, caveat, or question.
Morelli et al. (2013) conducted an editorial in Obesity and cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: